ONCOSCINT CR/OV DIN 02328712
Health Canada record
| Active ingredient(s) | SATUMOMAB PENDETIDE 1 MG |
|---|---|
| Dosage form | Kit |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 04-Mar-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hospira Healthcare India Pvt. Ltd. — licence , not currently licensed, last inspection rating NC (2017-07-10).
No Canadian shortage report is currently matched to this DIN.
Request a quote for ONCOSCINT CR/OV